Wordt geladen...
Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
The acquisition of endocrine resistance is a common obstacle in endocrine therapy of patients with oestrogen receptor-α (ERα)-positive breast tumours. We previously demonstrated that the BIG3–PHB2 complex has a crucial role in the modulation of oestrogen/ERα signalling in breast cancer cells. Here w...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Pub. Group
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3791465/ https://ncbi.nlm.nih.gov/pubmed/24051437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms3443 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|